7 Biotech Stocks Ready to Ride the Sector's Resurgence

Why do you want to consider biotech stocks? Simply, the narrative comes down to numbers and a possible rotation.First, the hard data supports bullishness in biotech stocks. According to Grand View Research, the underlying global industry reached a valuation of $1.55 trillion last year. Moving forward, experts project that the sector will expand at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030. At the culmination point, the space may be worth $3.88 trillion.Second, a sector rotation may be ...